Biological outcomes in disease-modification trials

被引：0
|
作者：
Galasko, D [1 ]
机构：
[1] UCSD, Dept Neurosci, San Diego, CA USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
37
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [21] Disease-Modification in Huntington's Disease: Moving Away from a Single-Target Approach
    Jensen, Melanie P.
    Barker, Roger A.
    JOURNAL OF HUNTINGTONS DISEASE, 2019, 8 (01) : 9 - 22
  • [22] Monoamine oxidase-B (MAO-B) inhibitors: Implications for disease-modification in Parkinson's disease
    Teo K.C.
    Ho S.-L.
    Translational Neurodegeneration, 2 (1)
  • [23] DISEASE-MODIFICATION BY A COMBINATORIAL TREATMENT OF ANTI-INFLAMMATORY DRUGS IN TWO RODENT MODELS OF EPILEPSY
    Iori, V.
    Frigerio, F.
    Pauletti, A.
    Rizzi, M.
    Torello, A.
    Ravizza, T.
    Vezzani, A.
    EPILEPSIA, 2015, 56 : 5 - 5
  • [24] Biological markers for disease modification
    Scheltens, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 6 - 6
  • [25] How can we assess disease-modification in AD? How can we design prevention studies?
    Fox, N
    MOVEMENT DISORDERS, 2002, 17 (06) : 1408 - 1408
  • [26] Outcomes for disease modifying trials
    Wilcock, G.
    JOURNAL OF NUTRITION HEALTH & AGING, 2007, 11 (04): : 318 - 319
  • [27] The Lessebo Effect in Disease Modification Trials in Parkinson's Disease
    Mestre, Tiago A.
    McDermott, Michael P.
    Lobo, Raquel
    Ferreira, Joaquim J.
    Lang, Anthony E. E.
    MOVEMENT DISORDERS, 2023, 38 (07) : 1346 - 1350
  • [28] Parkinson Disease-Modification Encompassing Rotenone and 6-Hydroxydopamine Neurotoxicity by the Microtubule-Protecting Drug Candidate SKIP
    Ivashko-Pachima, Yanina
    Seroogy, Kim B.
    Sharabi, Yehonatan
    Gozes, Illana
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2021, 71 (08) : 1515 - 1524
  • [29] Parkinson Disease-Modification Encompassing Rotenone and 6-Hydroxydopamine Neurotoxicity by the Microtubule-Protecting Drug Candidate SKIP
    Yanina Ivashko-Pachima
    Kim B. Seroogy
    Yehonatan Sharabi
    Illana Gozes
    Journal of Molecular Neuroscience, 2021, 71 : 1515 - 1524
  • [30] Caregiver outcomes in disease modifying trials
    Verhey, F. R. J.
    de Vugt, M. E.
    Aalten, P.
    Vernooij-Dassen, M. J.
    Byrne, E. J.
    Robert, P.
    JOURNAL OF NUTRITION HEALTH & AGING, 2007, 11 (04): : 342 - 344
12345